Search
Voyager Therapeutics Inc
VYGRAdd to Watchlist
3.780USD
+0.180+5.00%
Close 07/02, 13:00（ET）Quotes delayed by 15 min
208.69MMarket Cap
LossP/E TTM
Financial Health
Currency: USD Updated: 2026-07-02 The current financial score of Voyager Therapeutics Inc is 5.96, ranking 302 out of 387 in the Biotechnology & Medical Research industry. Its financial status is stable, and its operating efficiency is low. Its latest quarterly revenue reached 2.59M, representing a year-over-year decrease of 59.94%, while its net profit experienced a year-over-year decrease of 9.94%.
Financials
6.85
Cash and cash equivalents
Total assets
Total liabilities
Free cash flow
Relevant data have not been disclosed by the company yet.
Quality of Earnings
7.85
Total revenue
Operating profit
Total assets
SG&A
Relevant data have not been disclosed by the company yet.
Operational Efficiency
2.81
Cash flow from operating activities
Income after tax
Relevant data have not been disclosed by the company yet.
Growth Potential
5.19
Cash flow from operating activities
Total revenue
Relevant data have not been disclosed by the company yet.
Shareholder Returns
7.12
Free cash flow
Relevant data have not been disclosed by the company yet.